| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $6,877,118 ) |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY036910 | In vivo epigenetic reprogramming of retinal ganglion cells in aging mice with glaucoma | 000 | 2 | NIH | 6/1/2026 | $639,352 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY037707 | Navigation assistance using multimodal LLM and computer vision | 000 | 1 | NIH | 4/21/2026 | $878,988 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY037359 | Development of mini-USH2A gene therapy to treat Usher syndrome type 2A. | 001 | 1 | NIH | 6/3/2026 | $34,065 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY037359 | Development of mini-USH2A gene therapy to treat Usher syndrome type 2A. | 000 | 1 | NIH | 4/13/2026 | $423,866 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY037230 | Understanding the role of reactive astrocytes in glaucoma | 000 | 1 | NIH | 4/2/2026 | $545,948 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | UH3NS131518 | Anesthetic-Eluting Contact Lens for Corneal Pain | 000 | 3 | NIH | 4/21/2026 | $334,634 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY034111 | Mechanisms of immunological memory-mediated pathogenesis in chronic autoimmune uveitis | 000 | 4 | NIH | 5/13/2026 | $492,500 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | K99EY037781 | Hormonal Dynamics and Extracellular Vesicle Function in Keratoconus: Exploring Pathophysiology and Developing Targeted Therapies | 000 | 1 | NIH | 6/12/2026 | $132,837 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY025677 | Scanning and Detection at Intersections | 001 | 10 | NIH | 4/13/2026 | $903,101 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY020889 | Immunopathogenic Mechanisms of Dry Eye Disease | 000 | 16 | NIH | 12/4/2025 | $587,562 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY036009 | Optic neuropathy in familial dysautonomia: determination of disease mechanisms and functional rescue. | 000 | 2 | NIH | 4/7/2026 | $795,539 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY036033 | Alloimmune-compatible stem cells for ocular diseases | 000 | 2 | NIH | 1/12/2026 | $492,500 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY029727 | Contribution of Mast Cells in Non-Allergic Ocular Inflammation | 000 | 8 | NIH | 6/5/2026 | $492,500 |
| | 2026 | 2026 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY031696 | Innate and Adaptive Immunity in the Pathogenesis of Glaucoma | 001 | 6 | NIH | 6/23/2026 | $834,935 |
| | 2026 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R56EY037692 | Non-invasive Electrical Stimulation as a Therapy for Diabetic Keratopathy | 000 | 1 | NIH | 1/21/2026 | $0 |
| | 2026 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | K99EY036122 | Regulating host neural activity to improve retinal ganglion cell replacement therapies | 001 | 1 | NIH | 6/15/2026 | -$2,171 |
| | 2026 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | K99EY036122 | Regulating host neural activity to improve retinal ganglion cell replacement therapies | 000 | 1 | NIH | 6/8/2026 | $0 |
| | 2026 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | U01NS119560 | Humanization of a Notch 3 Agonist Antibody for Pre-Clinical Development of a CADASIL Treatment | 000 | 3 | NIH | 5/19/2026 | $0 |
| | 2026 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY032762 | Fas Ligand Cleavage regulates ocular homeostasis and glaucoma | 000 | 4 | NIH | 11/24/2025 | $0 |
| | 2026 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY024602 | Ocular Immune Regulation by Mesenchymal Stem Cells | 000 | 11 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY012963 | Mechanisms of Sensitization in High Risk Corneal Grafts | 000 | 26 | NIH | 5/11/2026 | $0 |
| | 2026 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R13EY037175 | The 9th Military Vision Symposium on Novel Technology and Vision Restoration. | 000 | 1 | NIH | 5/14/2026 | -$441 |
| | 2026 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY031696 | Innate and Adaptive Immunity in the Pathogenesis of Glaucoma | 000 | 5 | NIH | 6/11/2026 | $0 |
| | 2026 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01AI179898 | Characterization and optimization of single dose, thermostable and durable vaccine platform towards increased clinical acceptance | 000 | 1 | NIH | 12/3/2025 | -$668,569 |
| | 2026 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R13EY036700 | 33rd Biennial Cornea Conference | 000 | 1 | NIH | 11/25/2025 | $0 |
| | 2026 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | F32EY033211 | Regulating cell-cell interactions to improve donor retinal ganglion cell integration | 000 | 3 | NIH | 1/29/2026 | $0 |
| | 2026 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | K99EY033830 | Mechanisms of corneal stromal activation during regeneration and fibrosis by exosomes | 000 | 2 | NIH | 5/14/2026 | -$99 |
| | 2026 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY025677 | Scanning and Detection at Intersections | 000 | 9 | NIH | 4/3/2026 | $0 |
| | 2026 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | K99EY034938 | Partial epigenetic reprogramming of retinal pigment cells in age-related degeneration, dysfunction, and injury | 000 | 2 | NIH | 3/24/2026 | -$2,124 |
| | 2026 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY026539 | Investigation of endomucin as a novel regulator of angiogenesis | 000 | 8 | NIH | 5/14/2026 | -$1 |
| | 2026 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY024602 | Ocular Immune Regulation by Mesenchymal Stem Cells | 001 | 10 | NIH | 2/25/2026 | $0 |
| | 2026 | 2024 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | F32EY035529 | Sex difference in conjunctival epithelial cell response and their profile of extracellular bioactive lipids duringallergic inflammation | 000 | 2 | NIH | 6/23/2026 | -$48 |
| | 2026 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R21EY035298 | Personalizing Circumpapillary Retinal Nerve Fiber Layer Thickness Norms for Glaucoma | 000 | 1 | NIH | 4/16/2026 | $0 |
| | 2026 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY030575 | Personalizing Glaucoma Diagnosis by Disease Specific Patterns and Individual Eye Anatomy | 000 | 5 | NIH | 3/16/2026 | $0 |
| | 2026 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY031777 | Monocular Visual Confusion for Field Expansion | 000 | 4 | NIH | 4/16/2026 | $0 |
| | 2026 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY023385 | Visual Field Expansion Through Innovative Multi-periscopic Prism Design | 000 | 10 | NIH | 4/21/2026 | -$37,756 |
| | 2026 | 2023 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R56EY035213 | Mechanisms underlying mustard gas-induced conjunctival injury and use of lipid mediators as medical countermeasures | 000 | 1 | NIH | 4/16/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $14,900,716 ) (Continued on the next page) |
| | 2025 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY035215 | Immune Mechanisms of Chronic Ocular Damage after Acute Exposure to Nitrogen Mustard | 001 | 2 | NIH | 9/26/2025 | $196,998 |
| | 2025 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY033288 | The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival | 000 | 4 | NIH | 9/19/2025 | $418,625 |
| | 2025 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY034111 | Mechanisms of immunological memory-mediated pathogenesis in chronic autoimmune uveitis | 000 | 3 | NIH | 4/11/2025 | $492,500 |
| | 2025 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY035312 | Mechanisms of microglial neuroinflammatory response in glaucoma | 000 | 3 | NIH | 9/19/2025 | $418,625 |
| | 2025 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY032762 | Fas Ligand Cleavage regulates ocular homeostasis and glaucoma | 000 | 4 | NIH | 1/17/2025 | $588,524 |
| | 2025 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY031696 | Innate and Adaptive Immunity in the Pathogenesis of Glaucoma | 000 | 5 | NIH | 9/19/2025 | $610,152 |
| | 2025 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY036910 | In vivo epigenetic reprogramming of retinal ganglion cells in aging mice with glaucoma | 000 | 1 | NIH | 4/16/2025 | $679,159 |
| | 2025 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY024602 | Ocular Immune Regulation by Mesenchymal Stem Cells | 001 | 11 | NIH | 9/4/2025 | $1,477,500 |
| | 2025 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY036009 | Optic neuropathy in familial dysautonomia: determination of disease mechanisms and functional rescue. | 000 | 1 | NIH | 3/13/2025 | $638,267 |
| | 2025 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY020889 | Immunopathogenic Mechanisms of Dry Eye Disease | 000 | 15 | NIH | 11/22/2024 | $587,562 |
| | 2025 | 2025 | SCHEPENS EYE RESEARCH INSTITUTE, INC., THE | 20 STANIFORD ST | BOSTON | MA | 02114-2508 | SUFFOLK | USA | R01EY020581 | Role of Oxidative Stress in Pathogenesis of Fuchs Endothelial Corneal Dystrophy | 001 | 16 | NIH | 7/29/2025 | $602,106 |
|
